Comparative validation of computer programs for haplotype frequency estimation from donor registry data.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 23849067)

Published in Tissue Antigens on August 01, 2013

Authors

H-P Eberhard1, A S Madbouly, P A Gourraud, M L Balère, U Feldmann, L Gragert, H Maldonado Torres, J Pingel, A H Schmidt, D Steiner, H G M van der Zanden, M Oudshoorn, S G E Marsh, M Maiers, C R Müller

Author Affiliations

1: Zentrales Knochenmarkspender-Register Deutschland (ZKRD), Ulm, Germany.

Articles by these authors

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04

The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09

DNA finger printing by oligonucleotide probes specific for simple repeats. Hum Genet (1986) 3.41

Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22

Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant (2010) 2.87

The role of assembly in insulin's biosynthesis. Curr Opin Struct Biol (1998) 2.65

A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60

Congenital deficiency of vitamin K dependent coagulation factors in two families presents as a genetic defect of the vitamin K-epoxide-reductase-complex. Thromb Haemost (2000) 2.34

Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy. Br J Haematol (1997) 2.08

Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet (1999) 2.04

Recombined flanks of the variable and joining segments of immunoglobulin genes. Proc Natl Acad Sci U S A (1982) 2.03

A prospective, randomized study of intramedullary nails inserted with and without reaming for the treatment of open and closed fractures of the tibial shaft. J Orthop Trauma (2000) 2.01

The human gene for alkaptonuria (AKU) maps to chromosome 3q. Genomics (1994) 1.99

Assignment by deletion mapping of the steroid sulfatase X-linked ichthyosis locus to Xp223. Hum Genet (1980) 1.87

New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens (2003) 1.81

RYR1 mutations are a common cause of congenital myopathies with central nuclei. Ann Neurol (2010) 1.75

Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment. J Thromb Haemost (2011) 1.73

Sex chromosome positions in human interphase nuclei as studied by in situ hybridization with chromosome specific DNA probes. Hum Genet (1984) 1.62

Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant (2010) 1.60

Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther (2008) 1.59

[The Mannheim peritonitis index. An instrument for the intraoperative prognosis of peritonitis]. Chirurg (1987) 1.56

Characterization of duplication breakpoints in the factor VIII gene. J Thromb Haemost (2010) 1.52

Anaerobic pericarditis: case report and review. Clin Infect Dis (1994) 1.52

The probability of finding a suitable related donor for bone marrow transplantation in extended families. Blood (1996) 1.52

HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry. Leukemia (2000) 1.49

On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J Med Genet (1994) 1.47

Imaging of chronic inflammatory bowel disease with 18F-FDG PET in children and adolescents. Klin Padiatr (2013) 1.46

The Babel Tower revisited: SNPs - Indels - CNVs. Confusion in naming sequence variant always rises from ashes. Tissue Antigens (2009) 1.44

Molecular defects in alkaptonuria. Cytogenet Cell Genet (1997) 1.42

Regional assignment of the gene locus for steroid sulfatase. Hum Genet (1980) 1.40

Three mutant insulins in man. Nature (1983) 1.40

Proximal myotonic myopathy and proximal myotonic dystrophy: two different entities? The phenotypic variability of proximal myotonic syndromes. Neuromuscul Disord (2001) 1.39

Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth (2010) 1.39

X-linked steroid sulfatase: evidence for different gene-dosage in males and females. Hum Genet (1980) 1.37

Institutional conflict of interest. N Engl J Med (1995) 1.33

VKORC1: molecular target of coumarins. J Thromb Haemost (2007) 1.32

A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. Tissue Antigens (2011) 1.31

A novel cellulosomal scaffoldin from Acetivibrio cellulolyticus that contains a family 9 glycosyl hydrolase. J Bacteriol (1999) 1.31

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia (2009) 1.29

Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. Int J Androl (1999) 1.27

Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum Mol Genet (2001) 1.25

CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journals. Br J Dermatol (2009) 1.23

Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens (2013) 1.22

Fractures of the proximal part of the femur. Instr Course Lect (1995) 1.20

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire. Leukemia (2010) 1.20

KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics (2007) 1.19

A scaffoldin of the Bacteroides cellulosolvens cellulosome that contains 11 type II cohesins. J Bacteriol (2000) 1.18

Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant (2012) 1.17

Rapid isolation of a plant microsomal fraction by Mg2+--precipitation. FEBS Lett (1974) 1.17

Estimation of the male to female ratio of mutation rates from the segregation of X-chromosomal DNA haplotypes in Duchenne muscular dystrophy families. Hum Genet (1986) 1.16

The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Tissue Antigens (2009) 1.15

A bioinformatics approach to ascertaining the rarity of HLA alleles. Tissue Antigens (2009) 1.15

Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplant (2003) 1.14

Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology (2002) 1.14

Theoretical considerations on germline mosaicism in Duchenne muscular dystrophy. J Med Genet (1990) 1.12

Isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplant (2004) 1.12

Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant (2005) 1.11

Hot spot of recombination within DXS164 in the Duchenne muscular dystrophy gene. Am J Hum Genet (1989) 1.11

Human KIR sequences 2003. Immunogenetics (2003) 1.10

Berenil-induced undercondensation in human heterochromatin. Cytogenet Cell Genet (1989) 1.09

Genotype List String: a grammar for describing HLA and KIR genotyping results in a text string. Tissue Antigens (2013) 1.09

Abrogation of protein convertase 2 activity results in delayed islet cell differentiation and maturation, increased alpha-cell proliferation, and islet neogenesis. Endocrinology (2003) 1.08

Cloning of genomic sequences from the human Y chromosome after purification by dual beam flow sorting. Hum Genet (1983) 1.08

Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene. Neuromuscul Disord (2003) 1.06

A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. Int J Obes Relat Metab Disord (2004) 1.05

Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation. Bone Marrow Transplant (2011) 1.04

The quest for a bone marrow donor--optimal or maximal HLA matching? N Engl J Med (1998) 1.04

Chronic spondylogenic cervical myelopathy. A critical evaluation of surgical treatment after early and long-term follow-up. Neurosurg Rev (1993) 1.04

CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields. Bone Marrow Transplant (2009) 1.03

HLA-A, B, C, DR and DQ polymorphisms in three South African population groups: South African Negroes, Cape Coloureds and South African Caucasoids. Tissue Antigens (1988) 1.02

Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens. Hum Immunol (1996) 1.02

World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant (2007) 1.01

No evidence for linkage of autosomal dominant proximal spinal muscular atrophies to chromosome 5q markers. Hum Genet (1991) 1.00

World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant (2010) 1.00

Clinical and genetic evidence for autosomal dominant North Carolina macular dystrophy in a German family. Am J Ophthalmol (1997) 1.00

Ocular ochronosis in alkaptonuria patients carrying mutations in the homogentisate 1,2-dioxygenase gene. Br J Ophthalmol (1999) 1.00

Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox". Am J Physiol (1992) 1.00

Haemodynamics of hypertension in chronic renal disease. Contrib Nephrol (1977) 0.99

Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis (2000) 0.99

Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia. Bone Marrow Transplant (2002) 0.99

Overview of registries, HLA typing and diversity, and search algorithms. Tissue Antigens (2007) 0.99

Effect of administration of oral contraceptives in vivo on collagen synthesis in tendon and muscle connective tissue in young women. J Appl Physiol (1985) (2008) 0.99

Cloning of the homogentisate 1,2-dioxygenase gene, the key enzyme of alkaptonuria in mouse. Mamm Genome (1997) 0.99

Muscle injury induced beneath and distal to a pneumatic tourniquet: a quantitative animal study of effects of tourniquet pressure and duration. J Hand Surg Am (1991) 0.97

An update to HLA nomenclature, 2010. Bone Marrow Transplant (2010) 0.96